Patient Groups Urge Congress To Support Biosimilars
A coalition of 27 patient advocacy groups is urging U.S. lawmakers working on massive health care reform to include bipartisan amendments creating a regulatory pathway for generic versions of biologic drugs....To view the full article, register now.
Already a subscriber? Click here to view full article